1. Home
  2. NTRA vs FTI Comparison

NTRA vs FTI Comparison

Compare NTRA & FTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTRA
  • FTI
  • Stock Information
  • Founded
  • NTRA 2003
  • FTI 1884
  • Country
  • NTRA United States
  • FTI United States
  • Employees
  • NTRA N/A
  • FTI N/A
  • Industry
  • NTRA Medical Specialities
  • FTI Metal Fabrications
  • Sector
  • NTRA Health Care
  • FTI Industrials
  • Exchange
  • NTRA Nasdaq
  • FTI Nasdaq
  • Market Cap
  • NTRA 13.7B
  • FTI 11.5B
  • IPO Year
  • NTRA 2015
  • FTI N/A
  • Fundamental
  • Price
  • NTRA $129.95
  • FTI $24.72
  • Analyst Decision
  • NTRA Strong Buy
  • FTI Buy
  • Analyst Count
  • NTRA 15
  • FTI 11
  • Target Price
  • NTRA $123.64
  • FTI $29.33
  • AVG Volume (30 Days)
  • NTRA 1.2M
  • FTI 3.4M
  • Earning Date
  • NTRA 11-06-2024
  • FTI 10-24-2024
  • Dividend Yield
  • NTRA N/A
  • FTI 0.82%
  • EPS Growth
  • NTRA N/A
  • FTI N/A
  • EPS
  • NTRA N/A
  • FTI 1.01
  • Revenue
  • NTRA $1,360,503,000.00
  • FTI $8,505,100,000.00
  • Revenue This Year
  • NTRA $42.99
  • FTI $15.47
  • Revenue Next Year
  • NTRA $13.11
  • FTI $9.61
  • P/E Ratio
  • NTRA N/A
  • FTI $24.09
  • Revenue Growth
  • NTRA 46.13
  • FTI 19.08
  • 52 Week Low
  • NTRA $36.90
  • FTI $18.33
  • 52 Week High
  • NTRA $128.28
  • FTI $29.85
  • Technical
  • Relative Strength Index (RSI)
  • NTRA 66.43
  • FTI 40.64
  • Support Level
  • NTRA $114.62
  • FTI $22.99
  • Resistance Level
  • NTRA $118.52
  • FTI $27.09
  • Average True Range (ATR)
  • NTRA 4.62
  • FTI 0.67
  • MACD
  • NTRA 0.87
  • FTI -0.13
  • Stochastic Oscillator
  • NTRA 99.77
  • FTI 38.05

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About FTI TechnipFMC plc

TechnipFMC is the largest pure-play offshore oilfield service provider, offering integrated deep-water offshore oil and gas development solutions that span the full spectrum of subsea equipment and subsea engineering and construction services. The company also provides various surface equipment used with onshore oil and gas wells. TechnipFMC originated with the 2017 merger of predecessor companies Technip and FMC Technologies.

Share on Social Networks: